Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up

European Urology, 06/01/2012

In appropriately selected patients, radiofrequency ablation is an effective minimally invasive therapy for the treatment of cT1a renal cell carcinoma, yielding comparable long–term oncologic outcomes to nephron–sparing surgery.

Print Article Summary Cat 2 CME Report